Private Preview
Your health data belongs to you. Not to them.
Xanadu is the first Patient-Owned Data Trust built with end-to-end encryption, a consent kill-switch, and an 80/20 payout when your anonymized data helps research.
Every record is normalized to FHIR, the global health-data standard, so it's clean, portable, and ready anywhere. Your digital health passport -- one you own, carry, and control. No one else holds it.
The architecture
Four pillars. One sovereign trust.
Every piece of Xanadu is designed so your data never leaves your control -- even when it earns for you.
Your data is checked for accuracy and quality the moment it enters your trust, so what you own is clean and research-grade.
Your raw data stays encrypted and under your control, on your device or the cloud you choose. No one else holds the keys.
Your consent-controlled data store. Port it, purge it, or protect it with a single click. A consent revocation kill-switch that actually works.
When anonymized, verified data is leased to researchers, 80% of the proceeds go directly to you. We take 20% to run the trust.
Why it matters
This has already happened to real people. It cannot happen on Xanadu.
The payout model
The 80/20 Payout™
When a researcher licenses a pool of anonymized health data, 80 cents of every dollar comes back to the trust members whose data contributed. We keep 20 cents to operate the infrastructure, maintain compliance, and run the Sovereignty Scorecard audits.
No one profits more from your data than you do. That is the founding commitment.
Data value
The Xanadu Score™
The more verified, continuous data you contribute, the higher your Xanadu Score -- and the higher your share of each payout pool.
Wearables, provider records, lab results, pharmacy data. Each verified source raises your score.
Researchers pay a premium for longitudinal, gap-free records. Consistent data earns more.
A complete, continuous record is the highest-confidence tier and earns the largest share of each payout pool.
Be among the founding cohort.
Founding members get early access and the 80/20 payout before we open to the general public.
Join the waitlistBuilding a platform, or running research? Let's talk →